Embolic strokes of undetermined source: The case for a new clinical construct

The Lancet Neurology

Volumn 13, Issue 4, 2014, Pages 429-438

  Hart, Robert G ^a   Diener, Hans Christoph ^b   Coutts, Shelagh B ^c   Easton, J Donald ^d   Granger, Christopher B ^e   O'Donnell, Martin J ^f   Sacco, Ralph L ^g   Connolly, Stuart J ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c UNIVERSITY OF CALGARY   (Canada)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e DUKE UNIVERSITY   (United States)

^f NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^g UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ANTIVITAMIN K; APIXABAN; DABIGATRAN; RIVAROXABAN; WARFARIN;

ANTICOAGULATION; AORTA ARCH; ARTERY OCCLUSION; ATHEROSCLEROTIC PLAQUE; BRAIN ARTERY; BRAIN ISCHEMIA; CAROTID ATHEROSCLEROSIS; CEREBROVASCULAR ACCIDENT; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; ECHOGRAPHY; EMBOLIC STROKE OF UNDETERMINED SOURCE; HEART DISEASE; HUMAN; NEUROIMAGING; NOTE; PRIORITY JOURNAL; RECURRENT DISEASE; THROMBOEMBOLISM;

HUMANS; STROKE; THROMBOEMBOLISM;

EID: 84896079786     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(13)70310-7     Document Type: Note

References (143)

1. Sacco RL, Ellenberg JH, Mohr JP, et al. Infarcts of undetermined cause: the NINCDS Stroke Data Bank. Ann Neurol 1989, 25:382-390.
2. Kistler JP The risk of embolic stroke. Another piece of the puzzle. N Engl J Med 1994, 331:1517-1519.
3. Fisher M, Adams RD Observations on brain embolism with special reference to the mechanism of hemorrhagic infarction. J Neuropathol Exp Neurol 1951, 10:92-94.
4. Dalal PM, Shah PM, Aiyar RR Arteriographic study of cerebral embolism. Lancet 1965, 2:358-361.
5. Dalal PM, Shah PM, Sheth SC, Deshpande CK Cerebral embolism. Angiographic observations on spontaneous clot lysis. Lancet 1965, 1:61-64.
6. Liebeskind A, Chinichian A, Schechter MM The moving embolus seed during serial cerebral angiography. Stroke 1971, 2:440-443.
7. Yamaguchi T, Minematsu K, Choki J, Ikeda M Clinical and neuroradiological analysis of thrombotic and embolic cerebral infarction. Jpn Circ J 1984, 48:50-58.
8. Santamarina E, Penalba A, García-Berrocoso T, et al. Biomarker level improves the diagnosis of embolic source in ischemic stroke of unknown origin. J Neurol 2012, 259:2538-2545.
9. Sharifkazemi MB, Aslani A, Zamirian M, Moaref AR Significance of aortic atheroma in elderly patients with ischemic stroke. A hospital-based study and literature review. Clin Neurol Neurosurg 2007, 109:311-316.
10. Moustafa RR, Izquierdo-Garcia D, Jones PS, et al. Watershed infarcts in transient ischemic attack/minor stroke with > or = 50% carotid stenosis: hemodynamic or embolic?. Stroke 2010, 41:1410-1416.
11. Grotta JC Clinical practice. Carotid stenosis. N Engl J Med 2013, 369:1143-1150.
12. Georgiadis D, Grosset DG, Lees KR Transhemispheric passage of microemboli in patients with unilateral internal carotid artery occlusion. Stroke 1993, 24:1664-1666.
13. Barnett HJM Delayed cerebral ischemic episodes distal to occlusion of major cerebral arteries. Neurology 1978, 28:769-774.
14. Olsen TS, Skriver EB, Herning M Cause of cerebral infarction in the carotid territory. Its relation to the size and the location of the infarct and to the underlying vascular lesion. Stroke 1985, 16:459-466.
15. Hart RG Cardiogenic embolism to the brain. Lancet 1992, 339:589-594.
16. Srivastava TN, Payment MF Images in clinical medicine. Paradoxical embolism-thrombus in transit through a patent foramen ovale. N Engl J Med 1997, 337:681.
17. Kronzon I, Tunick PA Atheromatous disease of the thoracic aorta: pathologic and clinical implications. Ann Intern Med 1997, 126:629-637.
18. Barnett HJ Embolism in mitral valve prolapse. Annu Rev Med 1982, 33:489-507.
19. Meissner I, Khandheria BK, Heit JA, et al. Patent foramen ovale: innocent or guilty? Evidence from a prospective population-based study. J Am Coll Cardiol 2006, 47:440-445.
20. Mas J-L, Arquizan C, Lamy C, et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 2001, 345:1740-1746. the Patent Foramen Ovale and Atrial Septal Aneurysm Study Group.
21. Overell JR, Bone I, Lees KR Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies. Neurology 2000, 55:1172-1179.
22. Weimar C, Holle DN, Benemann J, et al. Current management and risk of recurrent stroke in cerebrovascular patients with right-to-left cardiac shunt. Cerebrovasc Dis 2009, 28:349-356. the German Stroke Study Collaboration.
23. Gu X, He Y, Li Z, et al. Comparison of frequencies of patent foramen ovale and thoracic aortic atherosclerosis in patients with cryptogenic ischemic stroke undergoing transesophageal echocardiography. Am J Cardiol 2011, 108:1815-1819.
24. Handke M, Harloff A, Olschewski M, Hetzel A, Geibel A Patent foramen ovale and cryptogenic stroke in older patients. N Engl J Med 2007, 357:2262-2268.
25. Kent DM, Ruthazer R, Weimar C, et al. An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke. Neurology 2013, 81:619-625.
26. Agmon Y, Khandheria BK, Gentile F, Seward JB Echocardiographic assessment of the left atrial appendage. J Am Coll Cardiol 1999, 34:1867-1877.
27. Lapeyre AC, Steele PM, Kazmier FJ, Chesebro JH, Vlietstra RE, Fuster V Systemic embolism in chronic left ventricular aneurysm: incidence and the role of anticoagulation. J Am Coll Cardiol 1985, 6:534-538.
28. Stöllberger C, Blazek G, Dobias C, Hanafin A, Wegner C, Finsterer J Frequency of stroke and embolism in left ventricular hypertrabeculation/noncompaction. Am J Cardiol 2011, 108:1021-1023.
29. Barnett HJM, Boughner DR, Taylor DW, Cooper PE, Kostuk WJ, Nichol PM Further evidence relating mitral-valve prolapse to cerebral ischemic events. N Engl J Med 1980, 302:139-144.
30. Chen O, Dontineni N, Nahlawi G, et al. Serial cardiac magnetic resonance imaging of a rapidly progressing liquefaction necrosis of mitral annulus calcification associated with embolic stroke. Circulation 2012, 125:2792-2795.
31. Stein JH, Soble JS Thrombus associated with mitral valve calcification. A possible mechanism for embolic stroke. Stroke 1995, 26:1697-1699.
32. Kohsaka S, Jin Z, Rundek T, et al. Impact of mitral annular calcification on cardiovascular events in a multiethnic community: the Northern Manhattan Study. JACC Cardiovasc Imaging 2008, 1:617-623.
33. Kizer JR, Wiebers DO, Whisnant JP, et al. Mitral annular calcification, aortic valve sclerosis, and incident stroke in adults free of clinical cardiovascular disease: the Strong Heart Study. Stroke 2005, 36:2533-2537.
34. Belkin RN, Hurwitz BJ, Kisslo J Atrial septal aneurysm: association with cerebrovascular and peripheral embolic events. Stroke 1987, 18:856-862.
35. Schneider B, Hanrath P, Vogel P, Meinertz T Improved morphologic characterization of atrial septal aneurysm by transesophageal echocardiography: relation to cerebrovascular events. J Am Coll Cardiol 1990, 16:1000-1009.
36. Agmon Y, Khandheria BK, Meissner I, et al. Frequency of atrial septal aneurysms in patients with cerebral ischemic events. Circulation 1999, 99:1942-1944.
37. Cabanes L, Mas JL, Cohen A, et al. Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than 55 years of age. A study using transesophageal echocardiography. Stroke 1993, 24:1865-1873.
38. Rancurel G, Marelle L, Vincent D, Catala M, Arzimanoglou A, Vacheron A Spontaneous calcific cerebral embolus from a calcific aortic stenosis in a middle cerebral artery infarct. Stroke 1989, 20:691-693.
39. Brockmeier LB, Adolph RJ, Gustin BW, Holmes JC, Sacks JG Calcium emboli to the retinal artery in calcific aortic stenosis. Am Heart J 1981, 101:32-37.
40. Zhang L, Harrison JK, Goldstein LB Echocardiography for the detection of cardiac sources of embolism in patients with stroke or transient ischemic attack. J Stroke Cerebrovasc Dis 2012, 21:577-582.
41. Zahuranec DB, Mueller GC, Bach DS, et al. Pilot study of cardiac magnetic resonance imaging for detection of embolic source after ischemic stroke. J Stroke Cerebrovasc Dis 2012, 21:794-800.
42. Albers GW, Comess KA, DeRook FA, et al. Transesophageal echocardiographic findings in stroke subtypes. Stroke 1994, 25:23-28.
43. Jones EF, Donnan GA, Calafiore P, Tonkin AM Transoesophageal echocardiography in the investigation of stroke: experience in 135 patients with cerebral ischaemic events. Aust N Z J Med 1993, 23:477-483.
44. Comess KA, DeRook FA, Beach KW, Lytle NJ, Golby AJ, Albers GW Transesophageal echocardiography and carotid ultrasound in patients with cerebral ischemia: prevalence of findings and recurrent stroke risk. J Am Coll Cardiol 1994, 23:1598-1603.
45. Young KC, Benesch CG Transesophageal echocardiography screening in subjects with a first cerebrovascular ischemic event. J Stroke Cerebrovasc Dis 2011, 20:503-509.
46. Jickling GC, Stamova B, Ander BP, et al. Prediction of cardioembolic, arterial, and lacunar causes of cryptogenic stroke by gene expression and infarct location. Stroke 2012, 43:2036-2041.
47. Seet RC, Friedman PA, Rabinstein AA Prolonged rhythm monitoring for the detection of occult paroxysmal atrial fibrillation in ischemic stroke of unknown cause. Circulation 2011, 124:477-486.
48. Flint AC, Banki NM, Ren X, Rao VA, Go AS Detection of paroxysmal atrial fibrillation by 30-day event monitoring in cryptogenic ischemic stroke: the Stroke and Monitoring for PAF in Real Time (SMART) Registry. Stroke 2012, 43:2788-2790.
49. Rizos T, Güntner J, Jenetzky E, et al. Continuous stroke unit electrocardiographic monitoring versus 24-hour Holter electrocardiography for detection of paroxysmal atrial fibrillation after stroke. Stroke 2012, 43:2689-2694.
50. Sposato LA, Klein FR, Jáuregui A, et al. Newly diagnosed atrial fibrillation after acute ischemic stroke and transient ischemic attack: importance of immediate and prolonged continuous cardiac monitoring. J Stroke Cerebrovasc Dis 2012, 21:210-216.
51. Alhadramy O, Jeerakathil TJ, Majumdar SR, Najjar E, Choy J, Saqqur M Prevalence and predictors of paroxysmal atrial fibrillation on Holter monitor in patients with stroke or transient ischemic attack. Stroke 2010, 41:2596-2600.
52. Miller DJ, Khan MA, Schultz LR, et al. Outpatient cardiac telemetry detects a high rate of atrial fibrillation in cryptogenic stroke. J Neurol Sci 2013, 324:57-61.
53. Ritter MA, Kochhäuser S, Duning T, et al. Occult atrial fibrillation in cryptogenic stroke: detection by 7-day electrocardiogram versus implantable cardiac monitors. Stroke 2013, 44:1449-1452.
54. Etgen T, Hochreiter M, Mundel M, Freudenberger T Insertable cardiac event recorder in detection of atrial fibrillation after cryptogenic stroke: an audit report. Stroke 2013, 44:2007-2009.
55. Higgins P, MacFarlane PW, Dawson J, McInnes GT, Langhorne P, Lees KR Noninvasive cardiac event monitoring to detect atrial fibrillation after ischemic stroke: a randomized, controlled trial. Stroke 2013, 44:2525-2531.
56. Pain D, Halperin JL Stroke: finding atrial fibrillation after cryptogenic stroke. Nat Rev Neurol 2012, 8:666-667.
57. Rabinstein AA, Fugate JE, Mandrekar J, et al. Paroxysmal atrial fibrillation in cryptogenic stroke: a case-control study. J Stroke Cerebrovas Dis 2013, 22:1405-1411.
58. Biblo LA, Yuan Z, Quan KJ, Mackall JA, Rimm AA Risk of stroke in patients with atrial flutter. Am J Cardiol 2001, 87:346-349. A9.
59. Kamel H, Elkind MSV, Bhave PD, et al. Paroxysmal supraventricular tachycardia and the risk of ischemic stroke. Stroke 2013, 44:1550-1554.
60. Engström G, Hedblad B, Juul-Möller S, Tydén P, Janzon L Cardiac arrhythmias and stroke: increased risk in men with high frequency of atrial ectopic beats. Stroke 2000, 31:2925-2929.
61. Todo K, Moriwaki H, Saito K, Naritomi H Frequent premature atrial contractions in stroke of undetermined etiology. Eur Neurol 2009, 61:285-288.
62. Fisher M, Kase CS, Stelle B, Mills RM Ischemic stroke after cardiac pacemaker implantation in sick sinus syndrome. Stroke 1988, 19:712-715.
63. Fairfax AJ, Lambert CD, Leatham A Systemic embolism in chronic sinoatrial disorder. N Engl J Med 1976, 295:190-192.
64. Healey JS, Connolly SJ, Gold MR, et al. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med 2012, 366:120-129. the ASSERT Investigators.
65. Freilinger TM, Schindler A, Schmidt C, et al. Prevalence of nonstenosing, complicated atherosclerotic plaques in cryptogenic stroke. JACC Cardiovasc Imaging 2012, 5:397-405.
66. Schwarz F, Bayer-Karpinska A, Poppert H, et al. Serial carotid MRI identifies rupture of a vulnerable plaque resulting in amaurosis fugax. Neurology 2013, 80:1171-1172.
67. Travedi RA, U-King-Im JM, Graves MJ, Gillard J, Kirkpatrick PJ Non-stenotic ruptured atherosclerotic plaque causing thromboembolic stroke. Cerebrovasc Dis 2005, 20:53-55.
68. Timsit SG, Sacco RL, Mohr JP, et al. Brain infarction severity differs according to cardiac or arterial embolic source. Neurology 1993, 43:728-733.
69. Kim JS, Nah H-W, Park SM, et al. Risk factors and stroke mechanisms in atherosclerotic stroke: intracranial compared with extracranial and anterior compared with posterior circulation disease. Stroke 2012, 43:3313-3318.
70. Nakamura T, Tsutsumi Y, Shimizu Y, Uchiyama S Ulcerated carotid plaques with ultrasonic echolucency are causatively associated with thromboembolic cerebrovascular events. J Stroke Cerebrovasc Dis 2013, 22:93-99.
71. Prabhakaran S, Rundek T, Ramas R, et al. Carotid plaque surface irregularity predicts ischemic stroke: the northern Manhattan study. Stroke 2006, 37:2696-2701.
72. Meissner I, Khandheria BK, Sheps SG, et al. Atherosclerosis of the aorta: risk factor, risk marker, or innocent bystander? A prospective population-based transesophageal echocardiography study. J Am Coll Cardiol 2004, 44:1018-1024.
73. Di Tullio MR, Sacco RL, Savoia MT, Sciacca RR, Homma S Aortic atheroma morphology and the risk of ischemic stroke in a multiethnic population. Am Heart J 2000, 139:329-336.
74. Di Tullio MR, Russo C, Jin Z, Sacco RL, Mohr JP, Homma S Aortic arch plaques and risk of recurrent stroke and death. Circulation 2009, 119:2376-2382. the Patent Foramen Ovale in Cryptogenic Stroke Study Investigators.
75. Amarenco P, Cohen A, Baudrimont M, Bousser M-G Transesophageal echocardiographic detection of aortic arch disease in patients with cerebral infarction. Stroke 1992, 23:1005-1009.
76. Davila-Roman VG, Barzilai B, Waring TH, Murphy SF, Schechtman KB, Kouchoukos NT Atherosclerosis of the ascending aorta: prevalence and role as an independent predictor of cerebrovascular events in cardiac patients. Stroke 1994, 25:2010-2016.
77. Park YH, Chun KJ, Kim JS, et al. Hail in silence! Mobile thrombus in the aortic arch. Circulation 2010, 122:2456-2458.
78. Amarenco P, Duyckaerts C, Tzourio C, Hénin D, Bousser M-G, Hauw J-J The prevalence of ulcerated plaques in the aortic arch in patients with stroke. N Engl J Med 1992, 326:221-225.
79. Amarenco P, Cohen A, Tzourio C, et al. Atherosclerotic disease of the aortic arch and the risk of ischemic stroke. N Engl J Med 1994, 331:1474-1479.
80. Atherosclerotic disease of the aortic arch as a risk factor for recurrent ischemic stroke. N Engl J Med 1996, 334:1216-1221. The French Study of Aortic Plaques in Stroke Group.
81. Macleod MR, Amarenco P, Davis SM, Donnan GA Atheroma of the aortic arch: an important and poorly recognised factor in the aetiology of stroke. Lancet Neurol 2004, 3:408-414.
82. Ferrari E, Vidal R, Chevallier T, Baudouy M Atherosclerosis of the thoracic aorta and aortic debris as a marker of poor prognosis: benefit of oral anticoagulants. J Am Coll Cardiol 1999, 33:1317-1322.
83. Dressler FA, Craig WR, Castello R, Labovitz AJ Mobile aortic atheroma and systemic emboli: efficacy of anticoagulation and influence of plaque morphology on recurrent stroke. J Am Coll Cardiol 1998, 31:134-138.
84. Fisher CM Lacunar strokes and infarcts: a review. Neurology 1982, 32:871-876.
85. Wessels T, Röttger C, Jauss M, Kaps M, Traupe H, Stolz E Identification of embolic stroke patterns by diffusion-weighted MRI in clinically defined lacunar stroke syndromes. Stroke 2005, 36:757-761.
86. Wardlaw JM, Smith C, Dichgans M Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. Lancet Neurol 2013, 12:483-497.
87. Benavente OR, Hart RG, McClure LA, Szychowski JM, Coffey CS, Pearce LA Effects of clopidogrel added to aspirin in patients with recent lacunar stroke. N Engl J Med 2012, 367:817-825. the SPS3 Investigators.
88. Jackson CA, Hutchison A, Dennis MS, Wardlaw JM, Lewis SC, Sudlow CL Differences between ischemic stroke subtypes in vascular outcomes support a distinct lacunar ischemic stroke arteriopathy: a prospective, hospital-based study. Stroke 2009, 40:3679-3684.
89. Lindsay P, Bayley M, Hellings C, Hill M, Woodbury E, Phillips S Canadian Best Practice Recommendations for stroke care (update 2008). Can Med Assoc J 2008, 179(suppl):1-25. (Canadian Stroke Strategy Best Practices and Standards Writing Group on behalf of the Canadian Stroke Strategy).
90. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 2008, 25:457-507. European Stroke Organisation (ESO) Executive Committee, the ESO Writing Committeethe ESO Writing Committee.
91. Moulin T, Tatu L, Vuillier F, Berger E, Chavot D, Rumbach L Role of a stroke data bank in evaluating cerebral infarction subtypes: patterns and outcome of 1,776 consecutive patients from the Besançon stroke registry. Cerebrovasc Dis 2000, 10:261-271.
92. Vemmos KN, Takis CE, Georgilis K, et al. The Athens stroke registry: results of a five-year hospital-based study. Cerebrovasc Dis 2000, 10:133-141.
93. Grau AJ, Weimar C, Buggle F, et al. Risk factors, outcome, and treatment in subtypes of ischemic stroke: the German stroke data bank. Stroke 2001, 32:2559-2566. The German Stroke Data Bank.
94. Mohr JP, Thompson JLP, Lazar RM, et al. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med 2001, 345:1444-1451. the Warfarin-Aspirin Recurrent Stroke Study Group.
95. Kolominsky-Rabas PL, Weber M, Gefeller O, Neundoerfer B, Heuschmann PU Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study. Stroke 2001, 32:2735-2740.
96. Murat Sumer M, Erturk O Ischemic stroke subtypes: risk factors, functional outcome and recurrence. Neurol Sci 2002, 22:449-454.
97. Bang OY, Lee PH, Joo SY, Lee JS, Joo IS, Huh K Frequency and mechanisms of stroke recurrence after cryptogenic stroke. Ann Neurol 2003, 54:227-234.
98. Soda T, Nakayasu H, Maeda M, et al. Stroke recurrence within the first year following cerebral infarction-Tottori University Lacunar Infarction Prognosis Study (TULIPS). Acta Neurol Scand 2004, 110:343-349.
99. Acciarresi M, Caso V, Venti M, et al. First-ever stroke and outcome in patients admitted to Perugia Stroke Unit: predictors for death, dependency, and recurrence of stroke within the first three months. Clin Exp Hypertens 2006, 28:287-294.
100. Sacco RL, Diener H-C, Yusuf S, et al. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med 2008, 359:1238-1251. the PRoFESS Study Group.
101. Nedeltchev K, Wiedmer S, Schwerzmann M, et al. Sex differences in cryptogenic stroke with patent foramen ovale. Am Heart J 2008, 156:461-465.
102. Michel P, Odier C, Rutgers M, et al. The Acute STroke Registry and Analysis of Lausanne (ASTRAL): design and baseline analysis of an ischemic stroke registry including acute multimodal imaging. Stroke 2010, 41:2491-2498.
103. Marnane M, Duggan CA, Sheehan OC, et al. Stroke subtype classification to mechanism-specific and undetermined categories by TOAST, A-S-C-O, and causative classification system: direct comparison in the North Dublin population stroke study. Stroke 2010, 41:1579-1586.
104. Ay H, Furie KL, Singhal A, Smith WS, Sorensen AG, Koroshetz WJ An evidence-based causative classification system for acute ischemic stroke. Ann Neurol 2005, 58:688-697.
105. B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial. Lancet Neurol 2010, 9:855-865. VITATOPS Trial Study Group.
106. Hankey GJ, Algra A, Chen C, et al. VITATOPS, the VITAmins TO prevent stroke trial: rationale and design of a randomised trial of B-vitamin therapy in patients with recent transient ischaemic attack or stroke (NCT00097669) (ISRCTN74743444). Int J Stroke 2007, 2:144-150. the VITATOPS Trial Study Group.
107. Bousser MG, Amarenco P, Chamorro A, et al. Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial. Lancet 2011, 377:2013-2022. the PERFORM Study Investigators.
108. Hennerici MG Rationale and design of the prevention of cerebrovascular and cardiovascular events of ischemic origin with terutoban in patients with a history of ischemic stroke or transient ischemic attack. Cerebrovasc Dis 2009, 27(suppl 3):28-32. the PERFORM Study Investigators.
109. Wolf ME, Sauer T, Alonso A, Hennerici MG Comparison of the new ASCO classification with the TOAST classification in a population with acute ischemic stroke. J Neurol 2012, 259:1284-1289.
110. Shang W, Liu J Stroke subtype classification: a comparative study of ASCO and modified TOAST. J Neurol Sci 2012, 314:66-70.
111. Nam HS, Kim HC, Kim YD, et al. Long-term mortality in patients with stroke of undetermined etiology. Stroke 2012, 43:2948-2956.
112. Romano JG, Arauz A, Koch S, et al. Disparities in stroke type and vascular risk factors between 2 Hispanic populations in Miami and Mexico City. J Stroke Cerebrovas Dis 2012, 22:828-833.
113. Vallejos J, Jaramillo A, Reyes A, et al. Prognosis of cryptogenic ischemic stroke: a prospective single-center study in Chile. J Stroke Cerebrovasc Dis 2012, 21:621-628.
114. Rodríguez-Yáñez M, Arias-Rivas S, Santamaría-Cadavid M, Sobrino T, Castillo J, Blanco M High pro-BNP levels predict the occurrence of atrial fibrillation after cryptogenic stroke. Neurology 2013, 81:444-447.
115. Adams HP, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993, 24:35-41.
116. Petty GW, Brown RD, Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO Ischemic stroke subtypes: A population-based study of functional outcome, survival, and recurrence. Stroke 2000, 31:1062-1068.
117. Amarenco P, Bogousslavsky J, Caplan LR, Donnan GA, Wolf ME, Hennerici MG The ASCOD phenotyping of ischemic stroke (Updated ASCO Phenotyping). Cerebrovasc Dis 2013, 36:1-5.
118. Shang WY, Liu JY Stroke subtype classification: a comparative study of ASCO and modified TOAST. J Neurol Sci 2012, 314:66-70.
119. Meschia JF, Barrett KM, Chukwudelunzu F, et al. Interobserver agreement in the trial of org 10172 in acute stroke treatment classification of stroke based on retrospective medical record review. J Stroke Cerebrovasc Dis 2006, 15:266-272. the Siblings with Ischemic Stroke Study (SWISS) Investigators.
120. Furlan AJ, Reisman M, Massaro J, et al. Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N Engl J Med 2012, 366:991-999. the CLOSURE I Investigators.
121. Homma S, DiTullio MR, Sacco RL, Sciacca RR, Mohr JP Age as a determinant of adverse events in medically treated cryptogenic stroke patients with patent foramen ovale. Stroke 2004, 35:2145-2149. the PICSS Investigators.
122. Arauz A, Murillo L, Márquez JM, et al. Long-term risk of recurrent stroke in young cryptogenic stroke patients with and without patent foramen ovale. Int J Stroke 2012, 7:631-634.
123. Almekhlafi MA, Wilton SB, Rabi DM, Ghali WA, Lorenzetti DL, Hill MD Recurrent cerebral ischemia in medically treated patent foramen ovale: a meta-analysis. Neurology 2009, 73:89-97.
124. Sacco RL, Prabhakaran S, Thompson JLP, et al. Comparison of warfarin versus aspirin for the prevention of recurrent stroke or death: subgroup analyses from the Warfarin-Aspirin Recurrent Stroke Study. Cerebrovasc Dis 2006, 22:4-12. the WARSS Investigators.
125. Homma S, Sacco RL, Di Tullio MR, Sciacca RR, Mohr JP Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study. Circulation 2002, 105:2625-2631. the PFO in Cryptogenic Stroke Study (PICSS) Investigators.
126. Longstreth WT, Kronmal RA, Thompson JLP, et al. Amino terminal pro-B-type natriuretic peptide, secondary stroke prevention, and choice of antithrombotic therapy. Stroke 2013, 44:714-719.
127. Connolly S, Pogue J, Hart R, et al. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial. Lancet 2006, 367:1903-1912. the ACTIVE Writing Group of the ACTIVE Investigators.
128. Connolly SJ, Eikelboom J, Joyner C, et al. Apixaban in patients with atrial fibrillation. N Engl J Med 2011, 364:806-817. the AVERROES Steering Committee and Investigators.
129. Homma S, Thompson JLP, Pullicino PM, et al. Warfarin and aspirin in patients with heart failure and sinus rhythm. N Engl J Med 2012, 366:1859-1869. the WARCEF Investigators.
130. Chatterjee S, Sardar P, Biondi-Zoccai G, Kumbhani DJ New oral anticoagulants and the risk of intracranial hemorrhage. Traditional and Bayesian meta-analysis and mixed treatment comparison of randomized trials of new oral anticoagulants in atrial fibrillation. JAMA Neurol 2013, 70:1486-1490.
131. Kearon C, Kahn SR, Agnelli G, Goldhaber S, Raskob GE, Comerota AJ Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-based Clinical Practice Guidelines (8th edn). Chest 2008, 133(suppl 6):454-545.
132. Brighton TA, Eikelboom JW, Mann K, et al. Low-dose aspirin for preventing recurrent venous thromboembolism. N Engl J Med 2012, 367:1979-1987. the ASPIRE Investigators.
133. Anand SS, Yusuf S Oral anticoagulant therapy in patients with coronary artery disease: a meta-analysis. JAMA 1999, 282:2058-2067.
134. Alexander JH, Lopes RD, James S, et al. Apixaban with antiplatelet therapy after acute coronary syndrome. N Engl J Med 2011, 365:699-708. the APPRAISE-2 Investigators.
135. Mega JL, Braunwald E, Wiviott SD, et al. Rivaroxaban in patients with a recent acute coronary syndrome. N Engl J Med 2012, 366:9-19. the ATLAS ACS 2-TIMI 51 Investigators.
136. Halkes PH, van Gijn J, Kappelle LJ, Koudstaal PJ, Algra A Medium intensity oral anticoagulants versus aspirin after cerebral ischaemia of arterial origin (ESPRIT): a randomised controlled trial. Lancet Neurol 2007, 6:115-124. the ESPRIT Study Group.
137. A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin. Ann Neurol 1997, 42:857-865. The Stroke Prevention in Reversible Ischemia Trial (SPIRIT) Study Group.
138. Granger CB, Alexander JH, McMurray JJV, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011, 365:981-992. the ARISTOTLE Committees and Investigators.
139. Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009, 361:1139-1151. the RE-LY Steering Committee and Investigators.
140. Albers GW, Amarenco P, Easton JD, Sacco RL, Teal P Antithrombotic and thrombolytic therapy for ischemic stroke (8th edn). Chest 2008, 133:630s-669S.
141. Adams RJ, Albers G, Alberts MJ, et al. Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke 2008, 39:1647-1652. the American Heart Association, the American Stroke Associationthe American Stroke Association.
142. Furie KL, Kasner SE, Adams RJ, et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011, 42:227-276. the American Heart Association Stroke Council, Council on Cardiovascular NursingCouncil on Cardiovascular Nursing, Council on Clinical CardiologyCouncil on Clinical Cardiology, Interdisciplinary Council on Quality of Care and Outcomes ResearchInterdisciplinary Council on Quality of Care and Outcomes Research.
143. Lansberg MG, O'Donnell MJ, Khatri P, et al. Antithrombotic and thrombolytic therapy for ischemic stroke: antithrombotic therapy and prevention of thrombosis, 9th edn: American College of Physicians evidence-based clinical practice guidelines. Chest 2012, 141:e601S-e636S.